Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell.
about
Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycleAn adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication.Identification of two nuclear subclasses of the adenovirus type 5-encoded DNA-binding protein.Adenovirus infection of primary malignant lymphoid cells.In vivo transcription from the adenovirus E2 early promoter by RNA polymerase III.Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell linesEfficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cellsNuclear localization of the adenovirus DNA-binding protein: requirement for two signals and complementation during viral infection.A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.The cellular transcription factor E2f requires viral E1A and E4 gene products for increased DNA-binding activity and functions to stimulate adenovirus E2A gene expressionMutations that affect phosphorylation of the adenovirus DNA-binding protein alter its ability to enhance its own synthesisConcentration dependence of transcriptional transactivation in inducible E1A-containing human cellsIsolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein.Inducible expression of herpes simplex virus type 2 glycoprotein gene gG-2 in a mammalian cell line.Sequences of herpes simplex virus type 1 that inhibit formation of stable TK+ transformants.New host cell system for regulated simian virus 40 DNA replication.Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene.Expression of a functional influenza viral cap-recognizing protein by using a bovine papilloma virus vector.Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.Recognition of the adenovirus type 2 origin of DNA replication by the virally encoded DNA polymerase and preterminal proteins.Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequencesRapid construction of adenoviral vectors by lambda phage genetics.Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity.Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo.Mitogenic activity of the adenovirus type 12 E1A gene induced by hormones in rat cells.Second-generation adenovirus vectors.Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection.
P2860
Q24557239-DD02A479-21BB-45BF-B255-2376BCBF7EC7Q27469506-AF48FFD6-BEB0-412E-BCA6-BED8E4B6E4A1Q32157164-7A3554AC-CB15-4A36-A316-7C7D6069E9DDQ33926774-106FBE42-C374-4647-BEE6-385BDC19DBB1Q34573981-28CD9557-846A-47CD-879C-362E379DF4BEQ35037853-A2FC166F-4711-458D-9E7B-A7ADFD907615Q35840871-99B58D50-185C-492E-A155-E09AD93812E7Q35853884-5A39E06C-C24A-4549-B9EA-F0273D915275Q36756929-A708B2C5-2747-4209-A34F-C1DE5D1F0964Q36762239-7C5D77E8-F783-487D-935B-2DFB5C6CED6DQ36808087-8F6B512D-BEC8-46E3-AB84-49E05CBA0A54Q36828421-FAF187F7-D2F3-4A5F-9537-91373D68AD7BQ36832209-2524C430-3044-4BB5-AA0C-57EFD4E7823DQ36848995-4E1F56F2-4A3D-49E8-BED1-23AA51E98CF1Q36854304-2E48F0CB-EEB7-4ABA-B575-D3B09A63D882Q36872956-FF346707-70A5-46A2-B4C7-128021F56DBBQ36919111-DCE5170B-C475-4512-8D28-FEFCED3E7EACQ36951834-664974C5-06D5-452C-B2BA-0253AA41B9AFQ37048872-359F8CDA-8399-4010-AA15-591CC8318911Q37522307-CAA56ABC-22EC-4815-A0DD-892DF61A12C4Q37652057-8562D5E5-AD68-462F-B865-BE5BA9DEAC28Q38330718-9FB75F25-D033-4BE5-8566-6CA609970A7CQ39601235-46D662D8-BAC7-4E04-BDB5-A607019CFD3FQ39683249-01C7CAFC-3C7A-4FC9-B180-E9366AC71841Q39876527-292F6021-1618-46FB-B60E-06FBE6F1FDF9Q39977061-5184FEA2-86BA-4578-A656-B678610CFF20Q40015350-3B9151FE-439F-4FB0-96C0-E1FFA0BBF9B0Q40126209-5E056C35-1696-4AA8-A2BF-CF327B64D308Q40939190-59EDBB9C-8B54-44E4-B807-C13B13BA7D1DQ45861528-4E0FF62C-12F9-41A7-AD9A-8B825FEB7A40
P2860
Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Introduction, stable integrati ...... c to the recipient human cell.
@en
type
label
Introduction, stable integrati ...... c to the recipient human cell.
@en
prefLabel
Introduction, stable integrati ...... c to the recipient human cell.
@en
P2093
P2860
P356
P1476
Introduction, stable integrati ...... c to the recipient human cell.
@en
P2093
D E Brough
D F Klessig
P2860
P304
P356
10.1128/MCB.4.7.1354
P407
P577
1984-07-01T00:00:00Z